Swot Analysis Of Glaxo Smith Kline

Every company has a set of strengths, weaknesses, opportunities, and threats. Even Foot Locker with its dismal situation in the United States still has strengths and opportunities. When doing any type of company analysis these categories need to be considered for they can be a clear indicator if this particular organization has a possible future. SWOT analysis involves specifying the objective of the business venture

I would suggest to a company to use the SWOT technique to find their strengths, weaknesses, opportunities and

For a company to create a SWOT analysis, they have to have a clear set objective so that they don’t face any serious problems such as wasting much needed time

A SWOT analysis is an analysis based on the strengths, weaknesses, opportunities, and threats of a company. SWOT analysis is the first phase in gathering information for strategic planning (Wheelen, Hunger, Hoffman, & Bamford, 2015). A SWOT analysis plays a significant role in strategic planning because it is the discovery phase of what the company needs to succeed. It is a tool used to examine a company’s state of health and improve on its opportunities. It gives a detailed understanding on areas that need attention as well as areas that are striving. It also gives companies a clear view of the advantages and disadvantages they have over their competitors. A SWOT analysis was created for The Home Depot to get a better understanding of the company and its strategic planning.

SWOT analysis allows for the creation of a plan of actions that is necessary for using a company’s strengths and for minimizing the effect of its weaknesses in order to increase the company’s opportunities and lower the risk of threats (Kolbina, 2015). Further, the SWOT analysis determines what assists the firm in accomplishing its objectives, and which problems need to be minimized to achieve the desired results. For instance, where the organization is currently at, and where it may need to be in the future.

To stronghold its strategic position in global Opiates market, it acquired GSK Australia's opiates business which enabled it to:

One of the largest pharmaceutical companies in the world today is GlaxoSmithKline PLC (GSK). GlaxoSmithKline PLC (GSK) was formed in December 2000 through a merger of

Compared to AZ and GSK, MRK had fewer drugs come off patent which has helped them maintain strong sales revenue.

The aim of this report is to analyse the financial position of Hikma Pharmaceutical PLC and GlaxoSmithKline PLC. The report will examine the firm’s daily operating activities and compares its performance with the closest competitor, the GlaxoSmithKline PLC. First, the report provides the industry overview and the background of both firms. Second, the report provides the segmented analysis in terms of products and geographical regions in order to better understand the performance of both firms. The report will then provide a financial ratio analysis of both firms in order to determine with certainty the best firm for investments The economic pressures including global crisis, price rise and increased rate of inflation and the general instability in the Eurozone affect both firms. The social, political and economic factors have a direct impact on the operating activities of both firms as well as their long-term growth decision plan. Finally After a careful examination of the financial ratios of both

1. SWOT matrix is an approach that is used to evaluate the strengths, weaknesses, opportunities as well as the threats that are associated with all the activities of the organization. An organization should conduct a SWOT analysis strategy with an aim of ensuring that it meets all its set goals. More so they will be at a position of identifying their competitors with whom they operate same businesses so as to ensure they remain competitive in the market. When evaluating the strength of an organization, organizations such as American Express should ensure that all the strengths of that organization are listed and more so it should ensure that

This assignment was prepared to understand and present an overview of GlaxoSmithKline (GSK), in the pharmaceutical industry and its competition against its distributors in Sri Lanka and also its market structure in view of its market structure at present in the industry.

GSK is the 2nd largest pharmaceutical firm in the world, and the largest in the UK by sales and profits, it is responsible for 7% of the worlds pharmaceutical market, and has its stocks listed both in UK and US (O 'Rourke, 2002). The origin of the so called blockbuster model, is partly linked with Glaxo (as it was previously known). In the early 80’s, then Glaxo brought to light their first blockbuster drug, Zantac, which was an anti-ulcer drug, which was very similar to the a pre existing drug Tagamet (first ever blockbuster) sold by Smith Kline & French, their completion at the time (MONTALBAN and SAKINÇ, 2011). The introduction of this drug, brought about an increasing sales force in the US, the company soon became dependent on the drug, because it represented a large part of their profit. In 2002, 8 blockbusters of GSK contributed to $14.240 million sales revenue, taking up 53% of its total ethical sales (Froud et al 2006). However, due to the nature of the pharmaceutical industry, the patent began to expire, in other to avoid the patent cliff, Glaxo merged with Wellcome in 1995, which ensured a growing number of sales force, and with Beecham in 2000 (Froud et al., 2006) this merger, boosted the confidence of investors, by growing the business inorganically. For Big Pharma, this block buster model is very profitable, because with the high cost of R&D, the drugs are able to generate ample profit, to cover the sunk costs

SWOT Analysis is a strategic planning method used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or project and identifying the internal and external factors that are favourable and unfavourable to achieving that objective. The technique is credited to Albert Humphrey, who led a research project at Stanford University in the 1960s and 1970s using data from Fortune 500 companies.[1]

This is a strategic analysis of GlaxoSmithKline that examines the key factors that influence the company and its activities. The strategic analysis will examine key factors in the company’s internal and external environment and their influence on the company’s strategies. GlaxoSmithKline is a global healthcare company that offers pharmaceutical, vaccines and consumer products. The company is a product of various mergers, the latest occurring in 2001 between GlaxoWellcome and SmithKline Beecham. The company started in London United Kingdom in 1715 as Plough Court pharmacy and has evolved to become one of the leading global healthcare companies. The healthcare company operates in more than 150 countries with 89 manufacturing locations and research centers in the USA, China, UK and Belgium. In 2015, the company’s sales grew to £23.9 billion from £23.0 billion in 2014 (GlaxoSmithKline plc. 2015).

The first important part of a SWOT analysis is to improve the viability of an organization. SWOT identifies the risk which can arise from future threats coupled with the organization weakness. For example, a pharma company ABC has invested heavily in R& D of existing product where a new competitor is also entering with same product. Then company ABC has to decide whether it is strategically important to deal with external threat or improve the internal weakness. Company ABC can continue the R & D progress to improve the quality of existing product or else can diversify the resource to offer the product at less cost i.e. improving its efficiency. So, SWOT plays an important role in such situation and proves to be a beneficial tool to take appropriate decision of improving the weakness